Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 601 - 650 out of 1,343

Document Document Title
JP2008247806A
To efficiently synthesize cyclic octadepsipeptide PF1022.The PF1022 represented by the general formula (II) (wherein, R1, R2, R3 and R4 represent each a hydrocarbon group which may have the same or different substituent) are efficiently ...  
JP4160115B2  
JP2008222568A
To provide an oligomer-type chiral salen compound, and to provide a method for producing the chiral compound from a racemic epoxide.The oligomer-type chiral salen compound is represented by formula (1). The method for producing the chira...  
JP4149532B2
Arylalkyldiazinone derivs. of formula (I) and their salts are new: B = aromatic heterocycle with 1-4H, O and/or S atoms bonded to N or C (opt. mono-, di- or tri-substd. by Hal, A and/or OA and opt. condensed with a benzene or pyridyl rin...  
JP2008528507A
The present invention explains arbitrarily at least one cardiovascular compound containing at least one heterocyclic nitric oxide donor machine, the composite containing at least one nitric oxide reinforcement compound and/or at least on...  
JP4126121B2  
JP2008526912A
R, R, V, V, X, X, Y, Z, Ar, AA, and n of the present invention are as the definition with a specification among the formula [化 1] [type of separated type or acid addition salt type, and the number of the ring atoms contained in this si...  
JP2008162953A
To provide a new cyclic ether amide lipid constructing molecular aggregates by self-organization, and a lipid membrane forming a moderate intramolecular hydrogen bond.This new cyclic ether amide lipid of 2 glycerol derivatives and 2 long...  
JP2008523059A
The compound of formula (I) or a stereoisomeric form, a tautomer, or its pharmacological composite that contains pharmacologically the salt which can be received or a solvation thing, and the compound of formula (I) is indicated. Moreove...  
JP4105805B2  
JP4106134B2  
JP2008520670A
The present invention is inhibitor of beta* secretase enzyme, and relates to the large annular tertiary-amine compound expressed to the medical treatment of the illness in which beta* secretase enzyme participates, for example, Alzheimer...  
JPWO2006080323A1
骨粗鬆症や骨折などの骨疾患、さらには緑内 障又は潰瘍性大腸炎の予防及び/又は治療に 有効な医薬の有効成分として利用可能な一般 式(I):[化1][Tは酸素原子等を示...  
JP2008520598A
The present invention relates to use of the 殺内部 verminousness デプシ peptide for manufacture of the medicine for prevention of perpendicular internal parasitism insect infection.  
JP4104653B2  
JP2008517965A
The manufacture method of [1, 4, 5] -オキシジアゼピン derivative by making 4 and 5-Zia シル- [1, 4, 5] -オキシジアゼピン react to a base.  
JP4090514B2
The present invention relates to compounds of the formula Q is selected from the group consisting of G is selected from the group consisting of alkyl, substituted alkyl, substituted or unsubstituted aryl, heterocyclo, W is O or NR15; X i...  
JP4090070B2  
JP2008515827A
general formula (I) of the present invention is new -- 1, 3, and a 4* オキサジ azine *5* ON derivative --those use for manufacturing the medicine used for those use for the disposal of those production methods and a disease, and/or p...  
JPWO2006011466A1
本発明に係る化合物、その医薬的に許容し得 る塩は、下記一般式(1)で表される。〔式 (1)中、R1、R2、R3、R4、Xは、明細 中のR1、R2、R3、R4、Xと同意義を...  
JP2008092952A
To provide an effective method for preparation of substituted aryl lactic acid containing cyclodepsipeptides.The invention relates to the new method for the preparation of substituted aryl lactic acid containing cyclodepsipeptides with 2...  
JP4070270B2  
JP4065053B2  
JP4054063B2  
JP2008503458A
The present invention offers the macrocyclic compound in which a new high order structure where it was proved that it is an alternative modulator (a growth hormone secretion promotion medicine receptor (GHS*R 1a) and its subtype, an iso ...  
JP4035852B2  
JP4033920B2  
JP4029047B2  
JP2007538106A
The present invention offers N* ring type sulfonamide compound for using it in the medical treatment or prevention of Alzheimer's disease etc. Of consciousness disorder. Especially an important compound is defined by formula (I) and R, R...  
JP2007314580A
To enhance the endoparasiticidal activity of cyclic depsipeptides. The present invention relates to the use of praziquantel and epsiprantel for enhancing the endoparasiticidal activity of cyclic depsipeptides in endoparasiticidal composi...  
JP2007535568A
The present invention offers the directions of the compound for dealing with or preventing the disease or obstacle relevant to activity of a compound, the medicine composite containing this compound, and the cathepsin S to apply.  
JP4016097B2  
JP2007534696A
The present invention relates to a composite and a method useful although it deals with a central nervous system (CNS) obstacle. Furthermore, the present invention offers the composite and method of dealing with sleep disorder. Furthermo...  
JP4015192B2  
JP2007533718A
The compound which has therapeutic utility R among a general formula (1) [type, Are H and C*C アルキル, are the thing which may be replaced by the case by F or C*C cycloalkyl, or C*C アルケニル, and; A, Are O, CH or S (O), and (...  
JP2007297303A
To provide an organic luminous element prevented from the depletion of luminous intensity. An organic luminous compound is provided, which has a specific structure having a site with the function of a dopant and the function of a host in...  
JP2007291121A
To provide a compound which is a stabilizer for microtubules useful for treating cancer or abnormal proliferative diseases. The compound is represented by formula V [wherein, Q is a saturated or an unsaturated 2C linking group which may ...  
JP4001381B2  
JP4001381B1  
JP3995300B2  
JP2007528420A
Muscarinic acetylcholine receptor antagonists and those directions for use are offered.  
JP3985050B2  
JP2007238510A
To provide an optically active compound highly sensitive and responsible in high speed. The optically active compound is expressed by general formula (I), wherein X1, X2, X3and X4express each independently -NH2, -N(CH3)2, -H, -CpF2p+1, -...  
JP2007501769A5  
JP2007524705A
As for the present invention, A is chosen from one or more X, Y, and/or Z basis among a general formula (I) : [type, X expresses the methylene machine which is not replaced [substitution or], and Y expresses C* アルケニレン which i...  
JP3968933B2
To provide high luminance and shelf life electroluminescent element and highly luminescent color filter based on that electroluminescent element by using inorganic and/or rare-earth complex based phosphor. An electroluminescent element c...  
JP3954127B2
PURPOSE: To obtain a new cyclic amide derivative exhibiting excellent weeding activity to injurious weed generating in paddy field or upland field in soil treatment or stem and leaf-treatment and exhibiting high safety to crop and useful...  
JP2007519639A
the present invention -- the compound (the inside of a formula, Het, A, A, A, A, and D --) of formula (I) W, T, Q, Y, X, X, R, R, R, R, k, and m are prescribed by this detailed in the letter one -- てい, [relate and] And when applicabl...  
JP2007182456A
To provide a herbicide having a selective action for killing only weeds without damaging crops, even when simultaneously applied to both the crops and the weeds.A cyclic amide derivative represented by the general formula [I] [-A-B- is -...  
JP3932559B2  

Matches 601 - 650 out of 1,343